Complete Genomics Reports Up to $4.3M in Preliminary Q3 Revenue; Ups IPO Target by $10M; Prices Shares

For the quarter ended Sept. 30, Complete Genomics recorded between $3.9 million and $4.3 million in revenue, from approximately 20 customers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.